Correlation Between LMF Acquisition and Humacyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LMF Acquisition and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LMF Acquisition and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LMF Acquisition Opportunities and Humacyte, you can compare the effects of market volatilities on LMF Acquisition and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LMF Acquisition with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of LMF Acquisition and Humacyte.

Diversification Opportunities for LMF Acquisition and Humacyte

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between LMF and Humacyte is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding LMF Acquisition Opportunities and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and LMF Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LMF Acquisition Opportunities are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of LMF Acquisition i.e., LMF Acquisition and Humacyte go up and down completely randomly.

Pair Corralation between LMF Acquisition and Humacyte

Assuming the 90 days horizon LMF Acquisition Opportunities is expected to generate 1.57 times more return on investment than Humacyte. However, LMF Acquisition is 1.57 times more volatile than Humacyte. It trades about 0.07 of its potential returns per unit of risk. Humacyte is currently generating about 0.1 per unit of risk. If you would invest  4.35  in LMF Acquisition Opportunities on November 9, 2024 and sell it today you would lose (0.36) from holding LMF Acquisition Opportunities or give up 8.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.25%
ValuesDaily Returns

LMF Acquisition Opportunities  vs.  Humacyte

 Performance 
       Timeline  
LMF Acquisition Oppo 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LMF Acquisition Opportunities are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, LMF Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.
Humacyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte showed solid returns over the last few months and may actually be approaching a breakup point.

LMF Acquisition and Humacyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LMF Acquisition and Humacyte

The main advantage of trading using opposite LMF Acquisition and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LMF Acquisition position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.
The idea behind LMF Acquisition Opportunities and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios